Here are the stock reports from five spine device companies for April 2, 2015 and how they compare to their numbers last week on April 2.
Spinal Tech
Integra LifeScience had their consensus rating updated from seven brokerages, according to a WKRB report.
The University of Delaware Research Foundation will give several Strategic Initiative Grants, each worth $45,000, to young researchers with faculty mentors for medical issues, one of which is focused on orthopedic disorders, according to a UDaily report.
Barclays downgraded Stryker shares, according to a Woodbridge Daily report.
Atlas Spine plans to raise money through OfferBoard Securities in Series B financing.
Advertisement
Results from the KAST trial, involving Benvenue Medical's Kiva VCF Treatment System and its efficacy as compared to balloon kyphoplasty, have been published in Spine.
Safe Orthopaedics announced the European launch of its new fenestrated screw.
K2M shares reached $23.89 on April 7, which a new 52-week high for the company, according to an Equities report.
Here are the mergers and acquisitions that took place among spine and orthopedic companies within the last two months.
SpineGuard released their first quarter 2015 financial report.